Abstract:Background: Alzheimer's disease (AD) and amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) are debilitating neurodegenerative diseases for which there are currently no cures. Familial cases with known genetic causes make up less than 10% of these diseases, and little is known about the underlying mechanisms that contribute to sporadic disease. Accordingly, it is important to expand investigations into possible pathways that may contribute to disease pathophysiology. Glycerophosphodiester phosphodiesterase 2 (GDE2 or GDPD5) is a membrane-bound enzyme that acts at the cell surface to cleave the glycosylphosphatidylinositol (GPI)-anchor that tethers distinct proteins to the membrane. GDE2 abnormally accumulates in intracellular compartments in the brain of patients with AD, ALS, and ALS/FTD, indicative of GDE2 dysfunction. Mice lacking GDE2 (Gde2KO) show neurodegenerative changes such as neuronal loss, reduced synaptic proteins and synapse loss, and increased Aβ deposition, raising the possibility that GDE2 disruption in disease might contribute to disease pathophysiology. However, the effect of GDE2 loss on behavioral function and learning/memory has not been characterized. Results: Here, we show that GDE2 is expressed throughout the adult mouse brain in areas including the cortex, hippocampus, habenula, thalamus, and amygdala. Gde2KO and WT mice were tested in a set of behavioral tasks between 7 and 16 months of age. Compared to WT, Gde2KO mice display moderate hyperactivity that becomes more pronounced with age across a variety of behavioral tests assessing novelty-induced exploratory activity. Additionally, Gde2KO mice show reduced startle response, with females showing additional defects in prepulse inhibition. No changes in anxiety-associated behaviors were found, but Gde2KOs show reduced sociability. Notably, aged Gde2KO mice demonstrate impaired short/long-term spatial memory and cued fear memory/secondary contextual fear acquisition. Conclusions: Taken together, these observations suggest that loss of GDE2 leads to behavioral deficits, some of which are seen in neurodegenerative disease models, implying that loss of GDE2 may be an important contributor to phenotypes associated with neurodegeneration.

Gatad2b , associated with the neurodevelopmental syndrome GAND, plays a critical role in neurodevelopment and cortical patterning

Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND)

Intellectual disability due to monoallelic variant in GATAD2B and mosaicism in unaffected parent

GATAD2B Gene Microdeletion Causing Intellectual Disability Autosomal Dominant Type 18: Case Report and Review of the Literature

Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases

The NuRD complex and macrocephaly associated neurodevelopmental disorders

GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila

GATAD2B is required for pre‐implantation embryonic development by regulating zygotic genome activation

Tissue-specific DNase I footprint analysis confirms the association of GATAD2B Q470* variant with intellectual disability

A novel mutation in the GATAD2B gene associated with severe intellectual disability

Correction: GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorder

Neuronal loss of Impairs O-glycosylation and Leads to Neurobehavioral Deficits Mimicking GALNT2-CDG

Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability

A neurodevelopmental disorder associated with a loss-of-function missense mutation in RAB35

Generation of a mouse model of the neurodevelopmental disorder with dysmorphic facies and distal limb anomalies syndrome

Loss of GDE2 leads to complex behavioral changes including memory impairment

ADGRL1 Haploinsufficiency Causes a Variable Spectrum of Neurodevelopmental Disorders in Humans and Alters Synaptic Activity and Behavior in a Mouse Model.

GATA-2 reinforces megakaryocyte development in the absence of GATA-1.

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

Further evidence supporting the role of GTDC1 in glycine metabolism and neurodevelopmental disorders

CC2D1A causes ciliopathy, intellectual disability, heterotaxy, renal dysplasia, and abnormal CSF flow